Transforming growth factors and histopathologic interpretation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3475298)

Published in J Am Acad Dermatol on July 01, 1987

Authors

K S Stenn, R L Barnhill, Y Johnston

Articles by these authors

A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12

The early clinical manifestations of Lyme disease. Ann Intern Med (1983) 5.73

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42

Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst (1996) 3.23

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68

A factual, not arbitrary, basis for choice of resection margins in melanoma. Arch Dermatol (1996) 2.12

Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06

Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel. Arch Dermatol (1997) 2.02

A quantitative model of invasive Pseudomonas infection in burn injury. J Burn Care Rehabil (1994) 1.91

Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat Genet (1999) 1.84

Spitz tumors in children: a grading system for risk stratification. Arch Dermatol (1999) 1.71

A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol (1994) 1.64

Telogen skin contains an inhibitor of hair growth. Br J Dermatol (1990) 1.64

Ectodermal dysplasias associated with clefting: significance of scalp dermatitis. J Am Acad Dermatol (1992) 1.63

Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol (1989) 1.59

Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol (1998) 1.40

Scd3--a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics (2001) 1.38

Leukemic vasculitis: a feature of leukemia cutis in some patients. Am J Clin Pathol (1997) 1.37

Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer (1995) 1.33

Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am J Pathol (1992) 1.29

Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer (1993) 1.27

Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest (1989) 1.22

The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. Lab Invest (1989) 1.22

Migrating epidermis produces AB2 collagen and requires continual collagen synthesis for movement. Nature (1979) 1.22

Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. Int J Epidemiol (1998) 1.21

Aortic endothelial cell migration. I. Matrix requirements and composition. Am J Pathol (1982) 1.16

Desmoplastic melanoma. Histopathology (1992) 1.14

Epibolin: a protein of human plasma that supports epithelial cell movement. Proc Natl Acad Sci U S A (1981) 1.12

Mechanism of bovine prothrombin activation by an insoluble preparation of bovine factor X a (thrombokinase). Biochemistry (1972) 1.12

Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol (1998) 1.11

Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res (1996) 1.10

Multiple mechanisms of dissociated epidermal cell spreading. J Cell Biol (1983) 1.09

Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas. Arch Dermatol (1993) 1.08

Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol (1996) 1.07

Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases. Am J Surg Pathol (1998) 1.07

Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J Am Acad Dermatol (1982) 1.07

Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma. J Clin Epidemiol (1999) 1.04

Analysis of vascularity of human neurofibromas. J Am Acad Dermatol (1998) 1.03

Increased thickness of pregnancy-associated melanoma. Br J Dermatol (1995) 1.02

Changes in expression of apoptosis-associated genes in skin mark early catagen. J Invest Dermatol (1995) 1.01

Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol (1996) 0.99

Fibroblast-dependent induction of a murine skin lesion with similarity to human common blue nevus. Am J Pathol (1996) 0.99

Histologic regression in malignant melanoma: an interobserver concordance study. J Cutan Pathol (1993) 0.97

Calcinosis cutis following extravasation of calcium chloride. Arch Dermatol (1988) 0.97

Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol (2006) 0.96

Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int J Cancer (1996) 0.95

Validation of a melanoma prognostic model. Arch Dermatol (1998) 0.95

Multiple primary cutaneous melanomas. Cancer (1992) 0.95

What is the biological basis of pattern formation of skin lesions? Exp Dermatol (2006) 0.93

Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol (1993) 0.93

The Spitz tumor 50 years later: revisiting a landmark contribution and unresolved controversy. J Am Acad Dermatol (1999) 0.92

Fibronectin (LETS) does not support epithelial cell spreading. J Invest Dermatol (1980) 0.92

Differential expression of the Hox 3.1 gene in adult mouse skin. Ann N Y Acad Sci (1991) 0.92

Small cell sweat gland carcinoma in childhood. Am J Surg Pathol (1998) 0.92

Primary malignant melanoma of the external auditory canal: a case report with presentation as an aural polyp. Am J Otol (1992) 0.91

Histologic spectrum of cutaneous involvement in patients with myelogenous leukemia including the neutrophilic dermatoses. Int J Dermatol (1995) 0.90

Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin. Lab Invest (1994) 0.90

Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol (1997) 0.90

Prenatal diagnosis of Sjögren-Larsson syndrome. J Pediatr (1982) 0.88

Malignant melanoma in situ: functional considerations of cancer. Hum Pathol (1990) 0.88

Evaluation of factors associated with skin self-examination. Cancer Epidemiol Biomarkers Prev (1999) 0.87

Human serum and epithelial spread in tissue culture. Arch Dermatol Res (1979) 0.87

Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas. Eur J Cancer (2003) 0.86

C16 laminin peptide increases angiotropic extravascular migration of human melanoma cells in a shell-less chick chorioallantoic membrane assay. Br J Dermatol (2007) 0.86

Ultrastructural and immunohistochemical studies of the periendothelial matrix in human melanoma: evidence for an amorphous matrix containing laminin. J Cutan Pathol (1999) 0.86

Epithelial growth by rat vibrissae follicles in vitro requires mesenchymal contact via native extracellular matrix. J Invest Dermatol (1990) 0.86

Spontaneous regression of cutaneous tumors. Adv Dermatol (1993) 0.86

The role of serum in the epithelial outgrowth of mouse skin explants. Br J Dermatol (1978) 0.86

Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study. J Cutan Pathol (1993) 0.86

Proliferation of eccrine sweat ducts associated with alopecia areata. J Cutan Pathol (1988) 0.86

Vitronectin: effects on keratinocyte motility and inhibition of collagen-induced motility. J Invest Dermatol (1991) 0.85

Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol (1998) 0.85

The importance of elastic fibres in skin lymphatics. Br J Dermatol (1983) 0.85

The epidermal pentapeptide pyroGlu-Glu-Asp-Ser-GlyOH inhibits murine hair growth in vivo and in vitro. Dermatologica (1991) 0.85

Epidemiology of cutaneous melanoma. An update. Dermatol Clin (1991) 0.84

Transection level dictates the pattern of hair follicle sheath growth in vitro. Dev Biol (1994) 0.84

Malignant blue nevus. Case report and literature review. J Am Acad Dermatol (1988) 0.84

Tumor microvessels in melanoma express the beta-2 chain of laminin. Implications for melanoma metastasis. J Cutan Pathol (1999) 0.84

Melanoma and extravascular migratory metastasis. J Cutan Pathol (2000) 0.84

Pagetoid Spitz nevus. Intraepidermal Spitz tumor with prominent pagetoid spread. Am J Surg Pathol (1995) 0.83

Tumour vascularity is not a prognostic factor for cutaneous melanoma. Lancet (1994) 0.83

Angiogenesis and regressing cutaneous malignant melanoma. Lancet (1992) 0.83

Dysplastic nevi in association with multiple primary melanoma. Cancer Res (1988) 0.83

Metastasizing atypical fibroxanthoma. Coexistence with chronic lymphocytic leukemia. Arch Dermatol (1978) 0.83

A survey of the prevalence of Escherichia coli O157 in raw meats, raw cow's milk and raw-milk cheeses in south-east Scotland. Int J Food Microbiol (2001) 0.83

Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis. Melanoma Res (2003) 0.82

Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI. Br J Cancer (1991) 0.82

Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas. J Immunol (1996) 0.82

A relation between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma. Epidemiology (1991) 0.81

Quantitative assay of dissociated tissue-cell motility in vitro. In Vitro (1980) 0.81

Fibroblast-dependent induction of a murine skin lesion similar to human nevus sebaceus of Jadassohn. Lab Invest (1997) 0.81

Prediction of histologic melanocytic dysplasia from clinical observation. J Am Acad Dermatol (1993) 0.81

Expression of basic fibroblast growth factor in desmoplastic melanoma. J Cutan Pathol (1996) 0.81

Studies on the anti-inflammatory properties of thalidomide: effects on polymorphonuclear leukocytes and monocytes. J Am Acad Dermatol (1984) 0.81

Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer (1980) 0.80

Identification of Borrelia burgdorferi in diffuse fasciitis with peripheral eosinophilia: borrelial fasciitis. JAMA (1994) 0.80

Marie Unna hereditary hypotrichosis gene maps to human chromosome 8p21 near hairless. J Invest Dermatol (2000) 0.80

Familial cutaneous melanoma. Melanoma Res (1995) 0.80